Portfolio

Learn more about the innovative companies Colorcon Ventures is investing in.

We invest in and support entrepreneurs developing transformational pharmaceutical and nutraceutical industry solutions.

Colorcon has partnered with Touchdown Ventures to manage Colorcon Ventures

Why work with us?

Syntis Bio

Offering a platform technology for oral therapies that target specific tissues, leading to better outcomes through increased bioavailability and higher efficacy for unmet conditions.

Learn More

Novome Biotechnologies

Exited

Atomwise

Through developing advanced Artificial Intelligence and Machine Learning solutions, Atomwise helps pharmaceutical industry overcome the challenges of drug discovery and create better medicines faster.

Learn More

i20 Therapeutics

Replacing the Syringe with a Pill, i2O Therapeutics has developed a disruptive ionic liquid technology that enables oral delivery of biologics and other injection-based drugs. The ability to deliver injectable therapies orally has the potential to significantly improve patient adherence and outcomes.

Learn More

Remedy Health

Leading provider of personalized 3D printed chewable nutritional gummies with a clean ingredient profile, Remedy leverages its patented 3D-printing technology to produce gummy vitamin stacks that are enjoyable and convenient to take as a single oral dose.

Learn More

Verisim Life

Through its bio-simulation platform, VeriSIM Life enables the pharmaceutical industry to narrow down most efficacious compounds, de-risk R&D decisions, predict preclinical outcomes prior to human trials, reduce animal testing and therefore facilitating speed to market at a lower cost.

Learn More

Apprentice

From small and large molecules to cell and gene therapy, solid oral dosages to injectables and beyond, Apprentice leverages artificial intelligence and augmented reality to get medicine to patients faster.

Learn More

mend.

Innovative clinical nutrition company, operating at the intersection of Nutra, Pharma and Digital wellness, providing value-based care and a data driven solution, focusing on patient engagement and adherence.

Learn More

Vedanta

Leading developer of a new class of therapeutics to modulate human microbiome based on rational design of defined consortia of bacteria that are essential for gut health.

Learn More